Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (33655) 33655
Newsletter (2291) 2291
Newspaper Article (438) 438
Magazine Article (169) 169
Book / eBook (122) 122
Book Chapter (52) 52
Conference Proceeding (33) 33
Web Resource (25) 25
Transcript (17) 17
Dissertation (12) 12
Reference (10) 10
Journal / eJournal (3) 3
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24074) 24074
science & technology (21418) 21418
life sciences & biomedicine (20271) 20271
mycoses (16939) 16939
male (12250) 12250
female (11205) 11205
infectious diseases (10957) 10957
bacterial infections and mycoses (10157) 10157
biological and medical sciences (9936) 9936
medical sciences (9610) 9610
adult (8278) 8278
middle aged (7928) 7928
microbiology (7066) 7066
antifungal agents - therapeutic use (6630) 6630
mycoses - drug therapy (5919) 5919
aged (5354) 5354
human mycoses (5099) 5099
antifungal agents (4977) 4977
health aspects (4806) 4806
animals (4124) 4124
research (4097) 4097
adolescent (3615) 3615
biochemical phenomena, metabolism, and nutrition (3459) 3459
pharmacology & pharmacy (3268) 3268
risk factors (3176) 3176
care and treatment (3171) 3171
immunology (3119) 3119
microbial sensitivity tests (3062) 3062
pharmacology. drug treatments (2996) 2996
child (2960) 2960
mycoses - microbiology (2874) 2874
treatment outcome (2830) 2830
infections (2806) 2806
dermatology (2733) 2733
research article (2718) 2718
antibiotics. antiinfectious agents. antiparasitic agents (2622) 2622
bacteria (2552) 2552
retrospective studies (2487) 2487
drug therapy (2349) 2349
medicine (2310) 2310
mycoses - diagnosis (2292) 2292
analysis (2276) 2276
abridged index medicus (2222) 2222
infection (2194) 2194
fungi (2186) 2186
amphotericin b - therapeutic use (2182) 2182
diagnosis (2123) 2123
anti-bacterial agents - therapeutic use (2100) 2100
mycology (2064) 2064
medical research (2044) 2044
antifungal agents - pharmacology (1961) 1961
antifungal agents - administration & dosage (1901) 1901
child, preschool (1894) 1894
fungal infections (1892) 1892
young adult (1817) 1817
mortality (1815) 1815
medicine, experimental (1813) 1813
polycyclic compounds (1785) 1785
aged, 80 and over (1730) 1730
antibiotics (1727) 1727
transplantation (1604) 1604
mycoses - etiology (1554) 1554
anti-bacterial agents - pharmacology (1541) 1541
general & internal medicine (1538) 1538
immunocompromised host (1527) 1527
epidemiology (1498) 1498
drug resistance (1489) 1489
patients (1471) 1471
infant (1444) 1444
mice (1399) 1399
mycoses - therapy (1337) 1337
mycoses - complications (1335) 1335
mycoses - prevention & control (1332) 1332
infectious and parasitic diseases (1293) 1293
pediatrics (1282) 1282
drug therapy, combination (1267) 1267
mycoses - epidemiology (1246) 1246
medicine, general & internal (1222) 1222
surgery (1211) 1211
candidiasis - drug therapy (1198) 1198
cancer (1175) 1175
prospective studies (1140) 1140
amphotericin b (1128) 1128
internal medicine (1127) 1127
tuberculosis (1107) 1107
hospitals (1091) 1091
aspergillosis (1089) 1089
hematology (1072) 1072
miscellaneous mycoses (1072) 1072
science & technology - other topics (1053) 1053
medicine & public health (1048) 1048
voriconazole (1045) 1045
tropical medicine (1035) 1035
multidisciplinary sciences (1014) 1014
fluconazole (1007) 1007
incidence (998) 998
physical fitness (990) 990
tropical mycoses (983) 983
bacterial diseases (982) 982
diagnosis, differential (975) 975
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (57) 57
Online Resources - Online (20) 20
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Scarborough Hospital - Online (3) 3
Gerstein Science - Circulation Desk (2) 2
UofT at Mississauga - Stacks (2) 2
Credit Valley Hospital - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Periodical Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (34856) 34856
German (803) 803
French (520) 520
Spanish (289) 289
Japanese (262) 262
Portuguese (247) 247
Russian (187) 187
Turkish (134) 134
Chinese (120) 120
Italian (101) 101
Polish (95) 95
Czech (37) 37
Dutch (29) 29
Hungarian (28) 28
Romanian (18) 18
Norwegian (12) 12
Swedish (11) 11
Finnish (10) 10
Danish (9) 9
Serbian (9) 9
Hebrew (8) 8
Slovak (6) 6
Croatian (5) 5
Ukrainian (5) 5
Bulgarian (3) 3
Arabic (2) 2
Korean (2) 2
Afrikaans (1) 1
Greek (1) 1
Lithuanian (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Empirical versus Preemptive Antifungal Therapy for High-Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial
by Catherine Cordonnier and Cécile Pautas and Sébastien Maury and Anne Vekhoff and Hassan Farhat and Felipe Suarez and Nathalie Dhédin and Francoise Isnard and Lionel Ades and Frédérique Kuhnowski and Françoise Foulet and Mathieu Kuentz and Patrick Maison and Stéphane Bretagne and Michaël Schwarzinger
Clinical infectious diseases, ISSN 1058-4838, 4/2009, Volume 48, Issue 8, pp. 1042 - 1051
Antifungals | Antibacterials | Induction chemotherapy | Sample size | Articles and Commentaries | Aspergillosis | Fungal infections | Consolidation chemotherapy | Fever | Neutropenia | Teaching hospitals | Hematologic and hematopoietic diseases | Other diseases. Hematologic involvement in other diseases | Infectious diseases | Pharmacology. Drug treatments | Antifungal agents | Biological and medical sciences | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Middle Aged | Male | Antibiotic Prophylaxis | Opportunistic Infections - prevention & control | Fever - physiopathology | Antifungal Agents - therapeutic use | Neutropenia - complications | Multicenter Studies as Topic | Statistics, Nonparametric | Amphotericin B - administration & dosage | Adult | Female | Deoxycholic Acid - administration & dosage | Mycoses - prevention & control | Risk Factors | Deoxycholic Acid - therapeutic use | Chi-Square Distribution | Opportunistic Infections - drug therapy | Mycoses - drug therapy | Mycoses - diagnosis | Aged | Mycoses - complications | Amphotericin B - therapeutic use | Antifungal Agents - administration & dosage | Drug Combinations | Care and treatment | Patient outcomes | Dosage and administration | Research | Drug therapy | Hyperthermia | Survival analysis | Chemotherapy | Antibiotics | Mortality | Clinical trials | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial
by Spellberg, Brad and Ibrahim, Ashraf S and Chin-Hong, Peter V and Kontoyiannis, Dimitrios P and Morris, Michele I and Perfect, John R and Fredricks, David and Brass, Eric P
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 3/2012, Volume 67, Issue 3, pp. 715 - 722
Antifungal | Fungal infections | Combination therapy | Mould infections | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Tropical mycoses | Pharmacology. Drug treatments | Mycoses | Biological and medical sciences | Phycomycoses | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Triazoles - administration & dosage | Mucormycosis - mortality | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Benzoates - administration & dosage | Drug Therapy, Combination - methods | Animals | Survival Analysis | Amphotericin B - administration & dosage | Adult | Female | Aged | Iron Chelating Agents - administration & dosage | Mice | Mucormycosis - drug therapy | Antifungal Agents - administration & dosage | Placebos - administration & dosage | Clinical trials | Drug therapy | Pathogenesis | Rodents | Mortality | Index Medicus | mould infections | antifungal | combination therapy | Original Research | fungal infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Combination Antifungal Therapy for Cryptococcal Meningitis
by Day, Jeremy N and Chau, Tran T.H and Chau, Nguyen V.V and Wolbers, Marcel and Mai, Nguyen H and Mai, Pham P and Dung, Nguyen T and Phu, Nguyen H and Nghia, Ho D and Phong, Nguyen D and Thai, Le H and Thai, Cao Q and Chuong, Ly V and Sinh, Dinh X and Duong, Van A and Hoang, Thu N and Diep, Pham T and Campbell, James I and Sieu, Tran P.M and Baker, Stephen G and Hien, Tran T and Lalloo, David G and Farrar, Jeremy J
The New England journal of medicine, ISSN 0028-4793, 04/2013, Volume 368, Issue 14, pp. 1291 - 1302
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Human mycoses | Infectious diseases | Pharmacology. Drug treatments | Antifungal agents | Mycoses | Biological and medical sciences | Medical sciences | Miscellaneous mycoses | Antibiotics. Antiinfectious agents. Antiparasitic agents | Antifungal Agents - adverse effects | Meningitis, Cryptococcal - drug therapy | Humans | Kaplan-Meier Estimate | Induction Chemotherapy | Male | Antifungal Agents - therapeutic use | Meningitis, Cryptococcal - mortality | Amphotericin B - adverse effects | Flucytosine - adverse effects | Flucytosine - therapeutic use | Adult | Female | Amphotericin B - therapeutic use | Drug Therapy, Combination | Drugs | Dose-response relationship (Biochemistry) | Usage | Cryptococcal meningitis | Amphotericin B | Patient outcomes | Flucytosine | Dosage and administration | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | Yeast | Fluconazole | Medical treatment | Mortality | Body weight | Clinical trials | Cerebrospinal fluid | Survival | Patients | Tropical diseases | Hospitals | Consent | Human immunodeficiency virus--HIV | Meningitis | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
by Andres Pascual and Thierry Calandra and Saskia Bolay and Thierry Buclin and Jacques Bille and Oscar Marchetti
Clinical infectious diseases, ISSN 1058-4838, 1/2008, Volume 46, Issue 2, pp. 201 - 211
Antifungals | Logistic regression | Azoles | Articles and Commentaries | Aspergillosis | Drug monitoring | Infections | Fungal infections | Dosage | Pharmacokinetics | Blood | Biological and medical sciences | Medical sciences | Pharmacology. Drug treatments | Antifungal agents | Antibiotics. Antiinfectious agents. Antiparasitic agents | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Chromatography, High Pressure Liquid - methods | Triazoles - blood | Pyrimidines - blood | Humans | Middle Aged | Mycoses - microbiology | Male | Candidiasis - microbiology | Candidiasis - blood | Candidiasis - drug therapy | Voriconazole | Adult | Female | Mycoses - blood | Retrospective Studies | Aspergillosis - blood | Aspergillosis - drug therapy | Pyrimidines - administration & dosage | Aspergillosis - microbiology | Mycoses - drug therapy | Pyrimidines - adverse effects | Aged | Drug Monitoring | Antifungal Agents - administration & dosage | Antifungal Agents - blood | Mycoses | Research | Drug therapy | Patient outcomes | Drug utilization | Studies | Pharmacology | Drug dosages | Chromatography | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Strategy of following Voriconazole versus Amphotericin B Therapy with Other Licensed Antifungal Therapy for Primary Treatment of Invasive Aspergillosis: Impact of Other Therapies on Outcome
by Thomas F. Patterson and Helen W. Boucher and Raoul Herbrecht and David W. Denning and Olivier Lortholary and Patricia Ribaud and Robert H. Rubin and John R. Wingard and Ben DePauw and Haran T. Schlamm and Peter Troke and John E. Bennett and Pfizer Global Aspergillus Study and EORTC IFIG and European Organization for Research and Treatment of Cancer (EORTC) Invasive Fungal Infections Group (IFIG) and Pfizer Global Aspergillus Study Group and for the European Organization for Research and Treatment of Cancer (EORTC) Invasive Fungal Infections Group (IFIG) and the Pfizer Global Aspergillus Study Group
Clinical infectious diseases, ISSN 1058-4838, 11/2005, Volume 41, Issue 10, pp. 1448 - 1452
Antifungals | Azoles | Major Articles | Polyenes | Aspergillosis | Medical specialists | Lipids | Experimentation | Fungal infections | Dosage | Salvage therapy | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Human mycoses | Infectious diseases | Pharmacology. Drug treatments | Antifungal agents | Mycoses | Biological and medical sciences | Antiparasitic agents | Medical sciences | Miscellaneous mycoses | Antibiotics. Antiinfectious agents. Antiparasitic agents | Itraconazole - therapeutic use | Pyrimidines - therapeutic use | Humans | Salvage Therapy | Voriconazole | Deoxycholic Acid - therapeutic use | Treatment Outcome | Amphotericin B - therapeutic use | Drug Combinations | Antifungal Agents - therapeutic use | Aspergillosis - drug therapy | Triazoles - therapeutic use | Care and treatment | Amphotericin B | Diagnosis | Research | Comparative analysis | Risk factors | Drug therapy | Respiratory diseases | Clinical outcomes | Effectiveness studies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Antifungal Therapy
by Perfect, John R and Ghannoum, Mahmoud A
2019, 2, ISBN 1498768148, 536
Infectious Diseases | Allergology & Clinical Immunology | Pharmaceutical Medicine | Antifungal agents
eBook
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
by Rahier, J.F and Magro, F and Abreu, C and Armuzzi, A and Ben-Horin, S and Chowers, Y and Cottone, M and de Ridder, L and Doherty, G and Ehehalt, R and Esteve, M and Katsanos, K and Lees, C.W and MacMahon, E and Moreels, T and Reinisch, W and Tilg, H and Tremblay, L and Veereman-Wauters, G and Viget, N and Yazdanpanah, Y and Eliakim, R and Colombel, J.F and on behalf of the European Crohn's and Colitis Organisation (ECCO) and ECCO and European Crohn's and Colitis Organisation (ECCO)
Journal of Crohn's and colitis, ISSN 1873-9946, 06/2014, Volume 8, Issue 6, pp. 443 - 468
Inflammatory bowel disease | ECCO guidelines | Opportunistic infections | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | HIV Infections - prevention & control | Hepatitis C - therapy | Age Factors | Herpesviridae Infections - etiology | Humans | Middle Aged | Opportunistic Infections - prevention & control | Opportunistic Infections - therapy | Papillomavirus Infections - diagnosis | Herpesviridae Infections - prevention & control | Papillomavirus Infections - therapy | Parasitic Diseases - etiology | Opportunistic Infections - etiology | Young Adult | Parasitic Diseases - therapy | HIV Infections - diagnosis | Mycoses - therapy | Adult | Influenza, Human - diagnosis | Papillomavirus Infections - etiology | Hepatitis C - prevention & control | Inflammatory Bowel Diseases - complications | Influenza, Human - therapy | Mycoses - prevention & control | Hepatitis B - therapy | Risk Factors | Parasitic Diseases - prevention & control | Herpesviridae Infections - diagnosis | Influenza, Human - etiology | Opportunistic Infections - diagnosis | Hepatitis B - diagnosis | Hepatitis B - etiology | Hepatitis C - diagnosis | HIV Infections - etiology | Herpesviridae Infections - therapy | Papillomavirus Infections - prevention & control | Adolescent | HIV Infections - therapy | Mycoses - diagnosis | Parasitic Diseases - diagnosis | Hepatitis B - prevention & control | Immunocompromised Host | Hepatitis C - etiology | Influenza, Human - prevention & control | Mycoses - etiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Dorothy Stopford Price
: rebel doctor
by Mac Lellan, Anne
2014, ISBN 9780716532361, xi, 268 p., 8 p. of plates
Stopford Price, Dorothy, 1890-1954 | Women physicians | Nationalists | Mass Vaccination | Ireland | Physicians, Women | history | Tuberculosis, Pulmonary
Book
Details down arrow
9. Full Text D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial
by Kanda, Yoshinobu and Kimura, Shun-Ichi and Iino, Masaki and Fukuda, Takahiro and Sakaida, Emiko and Oyake, Tatsuo and Yamaguchi, Hiroki and Fujiwara, Shin-Ichiro and Jo, Yumi and Okamoto, Akinao and Fujita, Hiroyuki and Takamatsu, Yasushi and Saburi, Yoshio and Matsumura, Itaru and Yamanouchi, Jun and Shiratori, Souichi and Gotoh, Moritaka and Nakamura, Shingen and Tamura, Kazuo and Japan Febrile Neutropenia Study Group and for the Japan Febrile Neutropenia Study Group
Journal of clinical oncology, ISSN 0732-183X, 03/2020, Volume 38, Issue 8, pp. 815 - 822
Hematologic Neoplasms - microbiology | Hematologic Neoplasms - therapy | Humans | Middle Aged | Fluconazole - administration & dosage | Male | Micafungin - administration & dosage | Young Adult | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Itraconazole - administration & dosage | Leukocyte Count | Mycoses - blood | Febrile Neutropenia - microbiology | Neutrophils - pathology | Mycoses - prevention & control | Febrile Neutropenia - blood | Febrile Neutropenia - drug therapy | Hematologic Neoplasms - blood | Hematologic Neoplasms - drug therapy | Aged | Hematopoietic Stem Cell Transplantation - methods | Antifungal Agents - administration & dosage | Mycoses - etiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Can intravenous antifungal therapy be safely used in the outpatient parenteral antimicrobial therapy (OPAT) setting?
by Rae, Nikolas and Kenny, Claire and Muldoon, Eavan G
Mycoses, ISSN 0933-7407, 03/2019, Volume 62, Issue 3, pp. 196 - 203
antifungal | patient safety | parenteral antifungal therapy | invasive candidosis | outpatient parenteral antimicrobial therapy | Life Sciences & Biomedicine | Dermatology | Mycology | Science & Technology | Ambulatory Care - methods | Administration, Intravenous | Antifungal Agents - administration & dosage | Humans | Mycoses - drug therapy | Mycoses | Antifungal agents | Intolerance | Intravenous administration | Fungal infections | Patients | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Antifungal photodynamic therapy
by Donnelly, Ryan F and McCarron, Paul A and Tunney, Michael M
Microbiological research, ISSN 0944-5013, 2008, Volume 163, Issue 1, pp. 1 - 12
Yeasts | Photosensitisers | Photodynamic antimicrobial chemotherapy | Dermatomycetes | Life Sciences & Biomedicine | Microbiology | Science & Technology | Aminolevulinic Acid - chemistry | Photosensitizing Agents - chemistry | Porphyrins - therapeutic use | Humans | Porphyrins - chemistry | Aminolevulinic Acid - therapeutic use | Photochemotherapy | Fungi | Photosensitizing Agents - administration & dosage | Radiation-Sensitizing Agents - therapeutic use | Animals | Mycoses - drug therapy | Indoles - therapeutic use | Antifungal Agents | Radiation-Sensitizing Agents - chemistry | Indoles - chemistry | Chemotherapy | Phthalocyanins | Antifungal agents | Mycoses | Health aspects | Porphyrins | Dyes and dyeing | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012
by Azie, Nkechi and Neofytos, Dionissios and Pfaller, Michael and Meier-Kriesche, Herwig-Ulf and Quan, Shun-Ping and Horn, David
Diagnostic microbiology and infectious disease, ISSN 0732-8893, 2012, Volume 73, Issue 4, pp. 293 - 300
Infectious Disease | Internal Medicine | Aspergillus | Candida | Invasive fungal infections | Mucormycetes | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Miscellaneous | Infectious diseases | Mycology | Biological and medical sciences | Medical sciences | Microbiological Techniques - methods | Mycoses - epidemiology | Humans | Mycoses - drug therapy | Survival Analysis | Mycoses - microbiology | International Cooperation | Mycoses - mortality | North America - epidemiology | Antifungal Agents - therapeutic use | Fluconazole | Stem cells | Antifungal agents | Mycoses | Transplantation | Health aspects | Hematopoietic stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights